Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial.

Saved in:

Bibliographic Details
Title:	Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial.
Authors:	Jifang Gong¹, Tianshu Liu², Qingxia Fan³, Li Bai⁴, Feng Bi⁵, Shukui Qin⁶, Jinwan Wang⁷, Nong Xu⁸, Ying Cheng⁹, Yuxian Bai¹⁰, Wei Liu¹¹, Liwei Wang¹², Lin Shen¹ lin100@medmail.com.cn, Gong, Jifang¹³ (AUTHOR), Liu, Tianshu² (AUTHOR), Fan, Qingxia³ (AUTHOR), Bai, Li⁴ (AUTHOR), Bi, Feng⁵ (AUTHOR), Qin, Shukui⁶ (AUTHOR), Wang, Jinwan¹⁴ (AUTHOR)
Source:	BMC Cancer. 2/8/2016, Vol. 16, p1-9. 9p. 1 Diagram, 2 Charts, 2 Graphs.
Database:	Academic Search Ultimate

Description
ISSN:	14712407
DOI:	10.1186/s12885-016-2092-9